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To the Editor: Parainfluenza virus 5 (PIV5), fam-
ily Paramyxoviridae, genus Rubulavirus, was previously 
known as simian virus 5 because of its discovery in primary 
monkey kidney cells in 1954 (1). PIV5 was later isolated 
from various hosts, including humans, dogs, pigs, cats, and 
rodents. The neutralizing antibody for PIV5 is detectable 
in symptomatic and asymptomatic humans; thus, its asso-
ciation with human disease remains controversial (2). In 
addition, previous studies have not documented illness in 
infected animals, except kennel cough in dogs (1,3). Isola-
tion of PIV5 from cattle has not previously been reported.
Since 2012, an infectious respiratory disease has been 
prevalent in weaning calves (≈10 d to 2 mo of age) in 
Baicheng City, Jilin Province, China. Initial clinical signs 
included secretion of clear nasal mucus, anorexia, slug-
gishness, and loss of body weight. After 10–20 d, ≈10% of 
the sick calves died of dyspnea and interstitial pneumonia. 
Farmers observed that 80%–90% of calves in the affected 
farms demonstrated clinical signs, but most recovered. All 
attempts of local veterinarians to treat the animals with var-
ious chemical compounds and antimicrobial drugs failed. 
The disease persists throughout the year but occurs mainly 
during spring (from February through March), which has 
resulted in substantial economic losses in the cattle industry.
To identify the causative agent of the disease, we test-
ed 15 lung samples from calves that had died and 10 lung 
samples from healthy calves that were slaughtered for se-
rum products (all from 1 farm). The samples were homog-
enized in phosphate-buffered saline and analyzed by using 
electron microscopy. Paramyxovirus-like particles were 
identified in the tissues of sick calves. Reverse transcrip-
tion PCR with the generic primers for the paramyxovirus 
polymerase gene was performed (4).
Of the 25 calf specimens, the 15 samples from the 
sick calves were positive by reverse transcription PCR, 
and amplicons of the expected size were obtained and se-
quenced. The generated sequences were closely related to 
the PIV5 sequences available from GenBank, particularly 
to sequences of the recently identified KNU-11 and SER 
viruses in pigs (5,6).
The suspensions of lung tissue from sick calves were 
purified by centrifugation at 12,000 × g for 5 min, and 0.2 
mL of the supernatant was added to a Vero cell monolayer 
in a 25-cm2 cell culture flask (EasyFlasks; Thermo Fisher 
Scientific, Odense, Denmark). After virus adsorption for 1 
h at 37°C, the cell monolayer was rinsed with phosphate-
buffered saline (pH 7.4) and then incubated in Dulbecco 
minimal essential medium/2% newborn calf serum at 37°C 
in a 5% CO2-humidified incubator. The infected cells were 
serially passaged every 3 days at 37°C and detected by us-
ing monoclonal antibody against SV5 (AbD Serotec; Bio-
Rad, Kidlington, UK) by indirect fluorescent antibody test 
(7). A PIV5 strain was isolated in the cell culture and desig-
nated PIV5-BC14 (BC14 stands for Baicheng City 2014).
For amplification and analysis of the full-length vi-
ral genome, 13 pairs of primers covering overlapping 
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fragments of the genome were designed on the basis of the 
sequence of the PIV5 isolate KNU-11 (8). The 3′ and 5′ 
termini of the genome were resolved by using the 3′ and 5′ 
Full RACE Kit (TaKaRa Biotechnology Co., Ltd., Dalian, 
China). The PIV5-BC14 genome (GenBank accession no. 
KM067467) was 15,246 nt with coding and untranslated 
regions at the same positions as in other PIV5 isolates (9). 
However, comparison of this genome with 15 available 
full-length genomes of PIVs revealed that 18 nt substitu-
tions, resulting in 9 aa changes, are found only in PIV5-
BC14. Among these 9 aa changes, 5 (at positions 303, 634, 
1054, 1722, and 1773) are present in an RNA-dependent 
RNA polymerase protein, 2 in a phosphoprotein (at posi-
tions 43 and 332), 1 in a nucleoprotein (at position 75), and 
1 in a hemagglutinin–neuraminidase (at position 322).
The highest nucleotide identity (99.72%/99.52%) 
was observed between PIV5-BC14 and porcine PIV, par-
ticularly with the SER virus isolate. This observation was 
confirmed after construction of a phylogenetic tree based 
on the 15 available nucleotide sequences of the full-length 
genomes (Figure). The analysis was carried out by using 
the maximum-likelihood method in MEGA 5.0 (10), and 
the reliability of tree topology was evaluated through boot-
strapping with 1,000 replicates.
Although the pathogenic role of PIV5 infections in 
cattle remains unknown, no PIV5 RNA was found in any 
apparently healthy cattle from the same farm. This result 
suggests a strong relationship between the identified virus 
and the disease.
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Figure. Maximum-likelihood 
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The black triangle indicates 
isolate PIV5-BC14 (Baicheng 
City 2014). Scale bar indicates 
nucleotide substitutions per site.
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To the Editor: Vaccinia virus (VACV) causes exan-
thematous disease (bovine vaccinia) in Brazil. Outbreaks 
of this disease in humans have been reported since the late 
1990s and have spread throughout Brazil (1). Natural hu-
man infections with VACV occur by close contact with 
infected cattle during milking. Lesions can spread to sec-
ondary body sites (forearms, arms, and face). Thus, person-
to-person transmission occurs (1).
Moreover, virus can persist in household environ-
ments, remain infectious, and be transmitted by fomites 
(2). Although raw milk and cheese are potential sources of 
infection, no clinical cases have been associated with this 
transmission route (3,4). Data for person-to-person trans-
mission in Brazil are scarce, but person-to-person transmis-
sion was recently reported (5). We report a possible case of 
person-to-person transmission of VACV.
This study was approved by the Research Ethics Com-
mittee of Universidade Federal de Minas Gerais (registra-
tion protocol FR-413704). In September 2012, during a 
serologic survey in a rural area of Serro City (18°36′17″S, 
43°22′46″W), Minas Gerais, Brazil (online Technical 
Appendix Figure, panel A, http://wwwnc.cdc.gov/EID/
article/21/12/14-1249-Techapp1.pdf), blood samples were 
obtained from a family of 5 persons (father, mother, and 3 
daughters). The father and mother were 48 and 53 years of 
age, respectively, and had been vaccinated against small-
pox. They reported contact with cows and horses (online 
Technical Appendix Table 1). Only the father had milked 
cows. The 3 daughters (13, 13, and 14 years of age) did 
not engage in any exposure activity. However, all family 
members had consumed raw milk and cheese.
Bovine vaccinia lesions were observed on the hand 
of the father (online Technical Appendix Figure, panel B). 
In 2011, he had vesicular disease (no laboratory diagno-
sis) with clinical and epidemiologic features (lesions) sug-
gestive of bovine vaccinia on his hands and forearms and 
systemic symptoms (fever, headache, malaise, myalgia, 
lymphadenopathy, and abdominal pain). His symptoms 
were mild and without any systemic clinical features. Two 
lesions developed on his hands and dried swab samples 
were collected from both lesions. Swab samples were pro-
cessed as described (2) and used for virus isolation and mo-
lecular diagnosis.
On the basis of previous studies that detected viral 
DNA in clinical samples from persons with bovine vac-
cinia (1), we used a quantitative PCR to amplify the vgf 
and ha genes of VACV (3–5), a standard PCR to detect 
the ha gene (3–5), and a seminested PCR to detect the ati 
gene (F.L. Assis, unpub. data). Serum samples were used 
for detection of virus-neutralizing antibodies (orthopoxvi-
rus 50% plaque-reduction neutralization test) and molecu-
lar diagnostic studies (1). Virus isolation was attempted 
in Vero cells and chorioallantoic membrane. All results 
were negative.
The 50% plaque-reduction neutralization test showed 
that the father, mother, and 14-year-old daughter had neu-
tralizing antibodies against orthopoxvirus (titers 800, 3,200, 
and 800 neutralizing units/mL, respectively). All family 
members had positive results by molecular diagnostic test 
for >1 virus gene (online Technical Appendix Table 1). To 
rule out infection with parapopoxvirus, a complementary 
PCR (6) was also performed, and all family members had 
negative results.
Quantitative PCR products for the ha gene from 3 vi-
rus-positive samples were sequenced in both directions in 
triplicate (Mega BACE Sequencer; GE Healthcare, Little 
Chalfont, UK). Sequences were aligned by using ClustalW 
(http://www.genome.jp/tools/clustalw/) and MEGA4.1 
(http://www.megasoftware.net/) and showed 100% iden-
tity with each other (Figure). A phylogenetic tree was 
constructed by using the neighbor-joining method and 
1,000-bootstrap replicates in the Tamura-3 parameter mod-
el (MEGA4.1). Sequences were grouped with VACV group 
2 isolates. Sequences obtained were deposited in GenBank 
under accession nos. KP889223–5).
In Brazil, outbreaks of bovine vaccinia are associ-
ated with rural environments. However, some clinical and 
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